Cargando…
Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
BACKGROUND: Multiple myeloma (MM) is one of the hitherto incurable malignant blood tumors. Bortezomib plays an important role in the treatment of MM. OBJECTIVE: We aimed to compare effectiveness, safety, and pharmacoeconomic evaluations of the original research drug and the generic drug Bortezomib i...
Autores principales: | Liang, Yongchao, Zhu, Ying, Zhang, Ying, Chen, Ziwei, Li, Boyang, Liu, Aijun, Liu, Lihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983228/ https://www.ncbi.nlm.nih.gov/pubmed/35392155 http://dx.doi.org/10.1155/2022/5201354 |
Ejemplares similares
-
Retracted: Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Drug Policy Research & Pharmacoeconomics
Publicado: (2008) -
Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients
por: Mersin, Sinan, et al.
Publicado: (2021) -
A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma
por: Kim, Youngwoon, et al.
Publicado: (2012) -
Recurrent Drug-Induced Hypersensitivity Syndrome Following Bortezomib for Multiple Myeloma
por: Ambur, Austin B, et al.
Publicado: (2021)